CNS Pharm Flashcards

1
Q

Triptans

A

Suma, riza, zolmi, nara, almo, etc.. are the first line Tx for severe migraines.

Affect the 5-HT1B/1D and inhibit the release of vasodilating neuropeptides.

Chest pain reported in 1-5% of cases due to coronary vasospasm.

Triptan duration of action is often shorter than duration of migraine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Prophylaxis for migraines: criteria and 5 drugs

A

2 or more attacks/month

Tx vacation every 4-6 months to evaluate

Propranolol: Beta-blocker
Amitriptyline: TCA
Verapamil: Ca2+ channel blocker
Valproic acid and topiramate: anti-seizure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

2 drugs for neuropathic pain and MOA

A

Carbamazepine and oxcarbazine

Na+ channel blockers (especially Na v 1.3 channels)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Methadone

A

Higher bioavailability than morphine

Its isomers can also block both NMDA receptors and monoaminergic reuptake transporters

Very effective for difficult-to-treat pain (neuropathic, cancer pain)

Long T1/2 (25-52 hours) Slower development of tolerance than morphine, Long lasting relief of pain

Widely used for treatment of opioid abuse, Abrupt cessation yields milder withdrawal signs

Unlike other opioids, is associated with prolonged QT syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Meperidine

A

Has significant antimuscarinic effects.

Unlike other opioids, causes mydriasis rather than miosis; IV administration frequently increases heart rate

Two severe reactions may result in patients also taking MAO inhibitors
Serotonin syndrome – can block neuronal reuptake of 5HT, resulting in serotonergic overactivity
Acute narcotic overdose – due to inhibition of hepatic CYPs by MAO inhibitors

Metabolized to normeperidine, which can cause increased CNS excitability and seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Fentanyl

A

Subgroups include su-, al-, remi-fentanil

Most widely used in anesthesia applications

Most lipid soluble (partition coefficient: 9550)

Relatively short time to peak analgesic effects
High abuse potential
Rapid termination

Cardiovascular safety (do not release histamine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Codeine, hydrocodone, oxycodone

A

Given in formulations containing acetaminophen or aspirin

Codeine metabolism is variable, not recommended for cancer pain management

Oxycodone is available in sustained-release form. Contains large quantities of oxycodone for prolonged action. Abuse potential due to modification of the tablets for injection or snorting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tramadol

A

Mixed mechanism opioid

Synthetic codeine analog that works centrally. Mechanism of action is based on both (weak) MOR activity and NE and 5HT reuptake blockade

Can cause seizures; contraindicated in patients taking MAO inhibitors, SSRIs or other drugs that lower seizure threshold

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nalbuphine
Butorphanol
Buprenorphine

A

Nalbuphine- no mu, lots kappa
Butorphanol- some mu, lots kappa
Buprenorphine- mu, no kappa

Effects of these drugs are not easily reversible with μ receptor antagonistsAll have ceiling effect for analgesia and respiratory depression
Butorphanol (less with nalbuphine) causes psychoto-mimetic side effects (dysphoria, racing thoughts, and distortions of body image)
Analgesia through KOR is more effective in women
Similar to methadone, buprenorphine has a long duration of action and is effective for treatment of opioid abuse; unlike methadone, high dose results in μ receptor antagonist action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Opioid Overdose

A

μ receptor antagonists are used for OD and to reverse opioid-induced respiratory depression
Both drugs have high affinity for MOR and lower affinity for DOR and KOR

Naloxone
Short duration of action (1-2 hours)
Administered parenterally in-clinic
Patient has to be monitored until it is certain that the offending opioid is no longer in system

Naltrexone
Long half-life (10 hours)
Administered orally in outpatient settings
Used in maintenance programs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

amitriptyline, nortriptyline

A

Neuropathic Pain

TCAs (amitriptyline, nortriptyline) blocks both Na+ channels and ↓ NE and 5HT reuptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

duloxetine, venlafaxine

A

Neuropathic Pain

SNRI (serotonin/ NE reuptake inhibitors) inhibits 5HT and NE reuptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

gabapentin, pregabalin

A

Neuropathic Pain

Calcium channel α2δ ligands (gabapentin, pregabalin) inhibit voltage-gated Ca2+ channels

Both are GABA analogs that increase presynaptic GABA release. Gabapentin bioavailability is unpredictable; pregabalin is more potent, has faster onset of action, and more predictable bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

lidocaine

A

Topical agents (lidocaine) reversibly blocks Na+ channels and prevents generation of action potential responsible for nerve conduction (pain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

carbamazepine, lamotrigine

A

Antiepileptic (carbamazepine, lamotrigine) blocks Na+ channels

Carbamazepine is 1st line for trigeminal neuralgia
Associated with risk of aplastic anemia

Lamotrigine is used in combination with carbamazepine for trigeminal neuralgia but has a high incidence of skin reactions which requires slow dose titration to mitigate these reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

dextromethorphan, ketamine

A

NMDA receptor antagonists (dextromethorphan, ketamine) may be used for chronic pain and postoperative pain

Both may produce psychomimetic side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

clonidine

A

Adrenergic Agonist (clonidine) acts on α2 receptors in the dorsal horn of the spinal cord to produce anti-nociceptive state

Associated postural hypotension limits its usefulness in pain management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

why is acyclovir more selectively toxic than other antivirals?

A

It attacks the viral kinases rather than the host cell kinases. This gives it more selective toxicity, but also renders it susceptible to resistance if the viral kinase is mutated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

name three viruses that acyclovir can be used against

A

HSV
EBV
VZV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

two indications for valacyclovir

A

Recurrent genital or zoster infections.

longer acting ester of acyclovir. converted to acyclovir when taken orally and gives 3-5 times the serum levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Two indications for famciclovir

A

For the management of acute herpes zoster and for the suppression of recurrent genital herpes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Apply the early symptoms and DOC for herpes encephalitis to a clinically-relevant case scenario

A

Any age, acute onset of fever, headache, decreased consciousness, and seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

how is ganciclovir metabolized to an active form inside host cells?

A

A guanosine analog.

Acts as an antimetabolite, which is phosphorylated first by viral (monophosphorylation) and then by cellular kinases (di –and tri phosphorylation) to form a nucleotide that inhibits DNA polymerase of CMV.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

how does cidofovir have selective toxicity

A

1000-fold more effective against the DNA polymerases of viruses such as herpes virus than against the DNA polymerase of the host cell

25
Q

what is unique about the metabolism requirement of foscarnet

A

Inhibits (in vitro) viral DNA polymerase, RNA polymerase, or HIV RT directly, without requirement for activation by phosphorylation.

26
Q

List four viruses attacked by foscarnet

A

HSV HHV-6
VZV HBV
CMV HIV
EBV

27
Q

Give the CDC guideline treatments for influenza in adults

A

Start treatment within 48 hours of symptom onset

28
Q

Explain the MOA of neuraminidase inhibitors

A

Inhibit viral cleavage of sialic acid

Inhibit the release of newly formed viruses

Reduce duration of uncomplicated influenza A and B infection symptoms by 1 day if started within 2 days of the onset of symptoms. May prevent up to 84% of influenza infections

29
Q

Explain the site of action for palivizumab

A

Binds to fusion (F) protein of RSV

Prevents infection of host cell, reduce replication of RSV and spread to other cells

30
Q

Explain the dosing and timing of palivizumab treatment for RSV

A

Dosing- 15 mg/kg IM monthly x up to 5 doses during RSV season with 1st dose given just prior to RSV season

Kinetics- t ½ 13-27 days (approximates human IgG t ½)
Onset: within 48 hrs

31
Q

Explain who should avoid contact with people receiving ribavirin and why

A

Planning to get pregnant or pregnant should avoid direct care of patients receiving inhaled ribavirin (it is teratogenic)

32
Q

Phenobarbital

A

Barbiturate
For pre-op sedation
Has slow onset
Produces hyperactivity in children

33
Q

Secobarbital

A

Barbiturate
For short term insomnia (less that 2 wks)
Also used for acute psychosis

34
Q

Zolpidem

A

Ambien
Z-hypnotic acts on GABA-A type 1 receptor

Sedative hypnotic with rapid onset

35
Q

Zaleplon

A

Sonata
Z-hypnotic acts on GABA-A type 1 receptor

Short acting and rapid onset
anxiolytic

36
Q

Propofol

A

Stimulated GABA release
Drug of choice for ambulatory Sx
Rapid metabolism and 99% changed before excretion

37
Q

Etomidate

A

Similar to propofol
Good for elderly pts as it doesn’t lower BP
NOT analgesic, and not as rapid as propofol

38
Q

Buspirone

A

acts on the 5-HT 1A receptor and decreased 5TH release and increases NE and DA

For long term anxiety- not for panic attacks
Not for use with BZ, so BZ must be tapered before use
No potential for abuse or withdrawal
can be taken with ETOH

39
Q

Ramelteon

A

melatonin receptor agonist

Shortens latency to sleep w/o rebound insomnia or withdrawal

40
Q

Fun facts for BZs

A

BZs are for short term use
Pt must be educated about sleep driving
Don’t take with ETOH
If pt doesn’t respond to a BZ don’t try others

41
Q

Alprazolam

A

BZ

For panic disorders

42
Q

Lorazepam

A

BZ- Ativan

For generalized anxiety disorder

43
Q

Meprobamate

A

BZ
Short term anxiety and sedative hypnotic
Decrease in REM sleep

44
Q

Midazolam

A

BZ

Can be used for pediatric pre-op

45
Q

Selegiline

A

Selective, irreversible MAO-B inhibitor -prevents DA breakdown!

Prolongs the effect of L-dopa, thereby allowing for smaller doses

May reduce the “on-off” effect
AE=insomnia

46
Q

Resagiline

A

Selective, irreversible MAO-B inhibitor -prevents DA breakdown!

Similar to selegiline, but also has a neuroprotective effect
Can be used as a mono therapy early in PD

47
Q

Entacapone

A

Selective COMP inhibitor
Prolongs the L-dopa activity- “on time”

Several adverse effects:

Dyskinesias
Nausea
Confusion
Orange peepee

48
Q

Tolcapone

A

Selective COMP inhibitor, like entacapone, but has increased liver toxicity

49
Q

Stalevo

A

L-dopa + carbidopa + etacapone

50
Q

Sinemet

A

L-dopa + Carbidopa

51
Q

Amantadine

A

Antiviral that just so happens to have anti parkinson effects!

Unknown MOA, but it enhances the DA function
Less potent than L-dopa
Tx only lasts a few weeks
Reduces all symptoms

52
Q

Bromocriptine

A

D2 receptor agonist
ergot derived
For parkinson disease

No enzymatic conversion needed
No toxic metabolite
No competition to cross the BBB
Few adverse effects

53
Q

Promipexole

A

D3 receptor agonist

Monotherapy for mild Parkinson disease
Adjunct therapy for severe PD
Dose adjustment needed for renal function

No enzymatic conversion needed
No toxic metabolite
No competition to cross the BBB
Few adverse effects

54
Q

Ropinerol

A

D2 receptor agonist
For parkinson disease

No enzymatic conversion needed
No toxic metabolite
No competition to cross the BBB
Few adverse effects

55
Q

Propranolol

A
Beta blocker (B1+B2)
Tx of essential tremor
56
Q

Metoprolol

A

Beta- blocker (B1)

57
Q

Tetrabenazine

A

For Tx of Huntington disease
Inhibits vessicular monoamine transporter 2
Precise MOA unknown

58
Q

Riluzole

A

Only drug specifically approved for ALS